Citations (18)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Wenyu Ye, William Montgomery, Zbigniew Kadziola, Li Liu, Haibo Xue, Michael D Stensland & Tamas Treuer. (2014) Factors associated with early response to olanzapine and clinical and functional outcomes of early responders treated for schizophrenia in the People’s Republic of China. Neuropsychiatric Disease and Treatment 10, pages 869-878.
Read now
Read now
Wenyu Ye, Haya Ascher-Svanum, Yuka Tanji, Jennifer A Flynn & Michihiro Takahashi. (2011) Predictors of continuation with olanzapine during the 1-year naturalistic treatment of patients with schizophrenia in Japan. Patient Preference and Adherence 5, pages 611-617.
Read now
Read now
Articles from other publishers (16)
Theodore R. ZarzarDavid L. RosenMichael T. KaneBrian B. Sheitman. (2022) The Natural History of Initial Antipsychotic Treatment Among Men Admitted to a State Prison. Psychiatric Services 73:10, pages 1169-1172.
Crossref
Crossref
Taishiro Kishimoto, Katsuhiko Hagi, Masahiro Nitta, John M. Kane & Christoph U. Correll. (2019) Long‐term effectiveness of oral second‐generation antipsychotics in patients with schizophrenia and related disorders: a systematic review and meta‐analysis of direct head‐to‐head comparisons. World Psychiatry 18:2, pages 208-224.
Crossref
Crossref
Miriam Wade, Sara Tai, Yvonne Awenat & Gillian Haddock. (2017) A systematic review of service-user reasons for adherence and nonadherence to neuroleptic medication in psychosis. Clinical Psychology Review 51, pages 75-95.
Crossref
Crossref
Ana Cardoso, Mitchell Byrne & Miguel Xavier. (2016) Adesão ao tratamento nas perturbações psiquiátricas: o impacto das atitudes e das crenças em profissionais de serviços de psiquiatria e saúde mental em Portugal. Parte I: aspetos conceptuais e metodológicos. Revista Portuguesa de Saúde Pública 34:3, pages 209-219.
Crossref
Crossref
Mantosh J. Dewan. (2016) The Psychology of Schizophrenia. Journal of Nervous & Mental Disease 204:8, pages 564-569.
Crossref
Crossref
Tak Lam Lo, Matthew Warden, Yanling He, Tianmei Si, Seshadri Kalyanasundaram, Manickam Thirunavukarasu, Nurmiati Amir, Ahmad Hatim, Tomas Bautista, Cheng Lee, Robin Emsley, Jose Olivares, Yen Kuang Yang, Ronnachai Kongsakon & David Castle. (2016)
Recommendations for the optimal care of patients with recent‐onset psychosis in the
A
sia‐
P
acific region
. Asia-Pacific Psychiatry 8:2, pages 154-171.
Crossref
Crossref
J. Volavka, R.A. Van Dorn, L Citrome, R.S. Kahn, W.W. Fleischhacker & P. Czobor. (2020) Hostility in schizophrenia: An integrated analysis of the combined Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) and the European First Episode Schizophrenia Trial (EUFEST) studies. European Psychiatry 31, pages 13-19.
Crossref
Crossref
S. Ramdour, J. A. Duxbury, G. Becket & S. Wilson. (2015) A cross-sectional observational study of healthcare professional views of factors affecting teenage adherence with antipsychotic medication. Journal of Psychiatric and Mental Health Nursing 22:7, pages 491-501.
Crossref
Crossref
Amal Abdel-Baki, Clairélaine Ouellet-Plamondon & Ashok Malla. (2012) Pharmacotherapy challenges in patients with first-episode psychosis. Journal of Affective Disorders 138, pages S3-S14.
Crossref
Crossref
Allen W Nyhuis, Douglas E Faries, Haya Ascher-Svanum, Virginia L Stauffer & Bruce J Kinon. (2010) Predictors of switching antipsychotic medications in the treatment of schizophrenia. BMC Psychiatry 10:1.
Crossref
Crossref
E. Habermeyer, R. Wolff, M. Gillner, R. Strohm & S. Kutscher. (2010) Patienten mit schizophrenen Störungen im psychiatrischen MaßregelvollzugPatients with psychotic disorders in forensic psychiatric hospitals. Der Nervenarzt 81:9, pages 1117-1124.
Crossref
Crossref
Se Hyun Kim Dong Chung Jung, Yong Min Ahn & Yong Sik Kim. (2009) The combined use of risperidone long-acting injection and clozapine in patients with schizophrenia non-adherent to clozapine: a case series. Journal of Psychopharmacology 24:7, pages 981-986.
Crossref
Crossref
Derek C. Stewart, Geraldine B. Anthony & Rosemary Chesson. (2010) ‘It's not my job. I’m the patient not the doctor’: Patient perspectives on medicines management in the treatment of schizophrenia. Patient Education and Counseling 78:2, pages 212-217.
Crossref
Crossref
Dawn I. Velligan, Peter J. Weiden, Martha Sajatovic, Jan Scott, Daniel Carpenter, Ruth Ross & John P. Docherty. (2010) Assessment of Adherence Problems in Patients with Serious and Persistent Mental Illness: Recommendations from the Expert Consensus Guidelines. Journal of Psychiatric Practice 16:1, pages 34-45.
Crossref
Crossref
Josep Maria Haro, Diego Novick, David Suarez & Mercedes Roca. (2009) Antipsychotic treatment discontinuation in previously untreated patients with schizophrenia: 36-month results from the SOHO study. Journal of Psychiatric Research 43:3, pages 265-273.
Crossref
Crossref
Peter F. Buckley. (2014) Update on the Etiology and Treatment of Schizophrenia and Bipolar Disorder. CNS Spectrums 13:S1, pages 1-12.
Crossref
Crossref